|
George A. Vandeman has been the principal of Vandeman & Co. a private investment firm since he retired in July 2000 from Amgen Inc. the world’s largest biotechnology company and where he continues as a part-time special advisor. From 1995 to 2000 Mr. Vandeman was senior vice president and general counsel of Amgen and a member of its Operating Committee. Immediately prior to joining Amgen in July 1995 Mr. Vandeman was a senior partner and head of the mergers and acquisitions practice at the international law firm of Latham & Watkins where he worked for nearly three decades. Mr. Vandeman is a member and past chair of the board of councilors at the University of Southern California Law School. | 